SEC Company Response from Genprex, Inc. (GNPX) (CIK 0001595248) (GNPX) — Sep 26, 2017
Genprex, Inc. (GNPX) (CIK 0001595248)
Date: Sept. 26, 2017 · CIK: 0001595248 · Accession: 0001193125-17-294631
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-219386
Letter
United States Securities and Exchange Commission Division of Corporation Finance Re: Genprex, Inc. Amendment No. 4 to Registration Statement on Form S-1 Filed September 22, 2017 File No. 333-219386
Dear Ms. Hayes:
Enclosed on behalf of our client, Genprex, Inc. (the “Company”), is Amendment No. 5 to Registration Statement on Form S-1 (“Amendment No. 5”). Amendment No. 5 updates the Company’s Registration Statement on Form S-1 originally filed with the Securities and Exchange Commission (the “Commission”) on July 21, 2017 (the “Registration Statement”), as amended by Amendment No. 1 filed with the Commission on August 18, 2017, Amendment No. 2 filed with the Commission on September 8, 2017, Amendment No. 3 filed with the Commission on September 15, 2017 and Amendment No. 4 filed with the Commission on September 22, 2017 (“Amendment No. 4”). The copy of Amendment No. 5 that is enclosed with the paper copy of this letter is marked to show changes from Amendment No. 4.
The Company respectfully requests the Staff’s assistance in completing the review of Amendment No. 5 as soon as possible. Please advise us if we can provide any further information or assistance to facilitate your review. Please direct any further comments or questions regarding the Amendment or this response letter to me at (512) 236-9908.
Sincerely,
STREUSAND, LANDON & OZBURN, LLP
Show Raw Text
CORRESP 1 filename1.htm Correspondence 811 Barton Springs Road Suite 811 Austin, Texas 78704 (512) 236-9908 (512) 236-9904 (fax) ozburn@slollp.com September 26, 2017 United States Securities and Exchange Commission Division of Corporation Finance Mail Stop 4546 100 F Street, N.E. Washington, D.C. 20549 Attn: Suzanne Hayes Re: Genprex, Inc. Amendment No. 4 to Registration Statement on Form S-1 Filed September 22, 2017 File No. 333-219386 Dear Ms. Hayes: Enclosed on behalf of our client, Genprex, Inc. (the “Company”), is Amendment No. 5 to Registration Statement on Form S-1 (“Amendment No. 5”). Amendment No. 5 updates the Company’s Registration Statement on Form S-1 originally filed with the Securities and Exchange Commission (the “Commission”) on July 21, 2017 (the “Registration Statement”), as amended by Amendment No. 1 filed with the Commission on August 18, 2017, Amendment No. 2 filed with the Commission on September 8, 2017, Amendment No. 3 filed with the Commission on September 15, 2017 and Amendment No. 4 filed with the Commission on September 22, 2017 (“Amendment No. 4”). The copy of Amendment No. 5 that is enclosed with the paper copy of this letter is marked to show changes from Amendment No. 4. The Company respectfully requests the Staff’s assistance in completing the review of Amendment No. 5 as soon as possible. Please advise us if we can provide any further information or assistance to facilitate your review. Please direct any further comments or questions regarding the Amendment or this response letter to me at (512) 236-9908. Sincerely, STREUSAND, LANDON & OZBURN, LLP /s/ Christopher J. Ozburn Christopher J. Ozburn cc: J. Rodney Varner, Genprex, Inc. Philip Magri, Magri Law LLC